Acucela (ACLA.RC)

Clinical-stage biotech developing treatments for eye diseases.

Other -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Acucela IPO News more
  • .
IPO Data
IPO File Date 12/17/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) n/a
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $n/a
 
Underwriters
more
Business Overview
Clinical-stage biotech developing treatments for eye diseases.
Clinical-stage biotech developing treatments for eye diseases.
more
Company Data
Headquarters Seattle, WA
Founded 2002
Employees 86
Website www.acucela.com
 

Performance vs. IPO Index (IPOUSA)